A substance being studied in the treatment of cancer. XL880 blocks enzymes involved in the growth and spread of tumor cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called foretinib and MET/VEGFR-2 inhibitor GSK1363089.